Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Acta pediatr. esp ; 71(8): e237-e244, sept. 2013. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-116761

RESUMO

La neurocisticercosis consiste en la afectación del SNC por el estado larvario de algunas tenias, generalmente Taenia solium. Endémica en prácticamente todos los países en desarrollo, es cada vez más frecuente en Europa por la inmigración y adopción internacional. Su diagnóstico se basa en datos clínicos, epidemiológicos, serológicos y de neuroimagen, clasificándose en definitivo o probable. Presentamos el caso de una niña colombiana de 6 años, con antecedente de crisis comicial, tras la que no recibió tratamiento antiepiléptico, que ingresa por estatus convulsivo controlado con la administración de diazepam y ácido valproico por vía endovenosa. Tras la realización de las pruebas complementarias, se establece un diagnóstico probable de neurocisticercosis cerebral en fase IV, por lo que se inició tratamiento con albendazol y dexametasona, manteniéndose el valproico oral. Evolucionó favorablemente, estando asintomática a los 6 meses del ingreso, con lesiones neurocisticercoides en resolución, permitiendo retirada progresiva del tratamiento anticomicial (AU)


The neurocysticercosis consists of CNS involvement by the larval stage of certain tapeworms, Taenia solium generally. Endemic in almost all developing countries, is increasing the frequency in Europe by immigration and international adoption. Diagnosis is based on clinical, epidemiological, serological and neuroimaging, classifying it in definitive or probable. We report the case of a Colombian girl six years old, with a history of seizure, after which she did not receive antiepileptic treatment, was admitted to the hospital with a status epileptic, which was controlled by the administration of diazepam and intravenous valproic acid. After performing additional tests, it was established a probable diagnosis of brain neurocysticercosis in stage IV, then she was treated with albendazole and dexamethasone, remaining the oral treatment with valproic acid. The patient evolution was favorable, being asymptomatic at 6 months after admission with neurocisticercoides injured in resolution, allowing the withdrawal of the anticonvulsant treatment (AU)


Assuntos
Humanos , Feminino , Criança , Estado Epiléptico/etiologia , Neurocisticercose/complicações , Taenia/patogenicidade , Anticonvulsivantes/uso terapêutico , Anti-Helmínticos/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...